Keywords: پروستات اسید فسفاتاز; Aβ; amyloid-beta; AFM; atomic force microscopy; ANS; 8-anilino-1-naphthalenesulfonate; αSNWT; wild-type α-synuclein; αSN103; C-terminally truncated α-synuclein; CD; circular dichroism; CTR; C-terminal region; DHPC; 1,2-dihexanoyl-sn-glycero-3-phospho
مقالات ISI پروستات اسید فسفاتاز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پروستات اسید فسفاتاز; prostatic neoplasms; immunotherapy; ADT; androgen deprivation therapy; APC; antigen presenting cell; CRPC; castration resistant prostate cancer; GM-CSF; granulocyte-macrophage colony-stimulating factor; mCRPC; metastatic castration resistant prostate canc
Keywords: پروستات اسید فسفاتاز; AMP; adenosine 5â²-monophosphate; ASIC; acid-sensitive ion channel; ATP; adenosine 5â²-triphosphate; CNS; central nervous system; CREB; cyclic AMP responsive element binding protein; DAG; diacylglycerol; ERK; extracellular signal-regulated protein kinas
Keywords: پروستات اسید فسفاتاز; AA; abiraterone acetate; ADT; androgen deprivation therapy; AR; androgen receptor; AR-V; AR splice variant; CRPC; castration-resistant prostate cancer; CTC; circulating tumor cell; CYP; cytochrome P450; FDA; Food and Drug Administration; LBD; ligand-bindi
A simple assay for direct colorimetric detection of prostatic acid phosphatase (PAP) at fg levels using biphosphonated loaded PEGylated gold nanoparticles
Keywords: پروستات اسید فسفاتاز; Prostatic acid phosphatase; Gold nanoparticles; Bisphosphonates; Colorimetric detection; Localized surface plasmon resonance;
Homotropic allostery of nucleotidase activity of human prostatic acid phosphatase
Keywords: پروستات اسید فسفاتاز; Adenosine; Homotropic allostery; Nucleotidase; Positive cooperativity in substrate binding; Prostatic acid phosphatase
Antitumor dendritic cell-based vaccines: lessons from 20Â years of clinical trials and future perspectives
Keywords: پروستات اسید فسفاتاز; APCs; antigen-presenting cells; cDCs; classical DCs; CTLs; cytotoxic T cells; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; DC; dendritic cell; Dex; dendritic cell-derived exosomes; EMA; European Medicines Agency; FDA; Food and Drug Administratio
Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy
Keywords: پروستات اسید فسفاتاز; A1R; adenosine A1 receptor; CGRP; calcitonin gene-related peptide; CPA; N6-cyclopentyladenosine; DRG; dorsal root ganglia; ECL; Enhanced Chemiluminescence reagent; hPAP; human prostatic acid phosphatase; IB4; isolectin IB4; ITU; 5â²-iodotubercidin; NT5E;
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
Keywords: پروستات اسید فسفاتاز; BCG; Bacillus Calmette-Guérin; BMDC; bone marrow-derived dendritic cell; CTA; cancer/testis antigen; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T lymphocyte antigen-4; DC; dendritic cell; DNA; deoxyribonucleic acid; DTH; delayed-type hypersensitivity
Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor
Keywords: پروستات اسید فسفاتاز; AcP; acid phosphatase; AI; androgen-independent; AS; androgen-sensitive; cPAcP; cellular prostatic acid phosphatase; CR PCa; castration-resistant prostate cancer; DSP; dual specificity phosphatase; EGFR; epidermal growth factor receptor; HER-2/ErbB-2/neu;
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
Keywords: پروستات اسید فسفاتاز; DC; dendritic cell; LN; lymph node; ODN; oligonucleotide; PAMP; pathogen-associated molecular pattern; PAP; prostatic acid phosphatase; PO; phosphodiester; PS; phosphorothioate; PRR; pattern recognition receptor; SVP; synthetic vaccine particle; Tfh; foll
Prostate cancer stem cells: Are they androgen-responsive?
Keywords: پروستات اسید فسفاتاز; ABC; ATP-binding cassette; ADT; androgen deprivation therapy; ALDH; aldehyde dehydrogenase; AML; acute myeloid leukaemia; AR; androgen receptor; BM; basement membrane; CaP; prostate cancer; CARN; castration-resistant nkx3.1-expressing cells; CB; committed
Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats
Keywords: پروستات اسید فسفاتاز; Adenosine; Prostatic acid phosphatase; Cerebral ischemia; Neuroprotection; Ecto-5′-nucleotidase
Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease
Keywords: پروستات اسید فسفاتاز; Prostate cancer; Proximal fluid; Prostate specific antigen; Prostatic acid phosphatase; Biomarker
Stereoselectivity of binding of α-(N-benzylamino)benzylphosphonic acids to prostatic acid phosphatase
Keywords: پروستات اسید فسفاتاز; Aminophosphonic acid; Prostatic acid phosphatase; Inhibition; Molecular modeling; Binding mode
Highly sensitive and rapid tandem bioluminescent immunoassay using aequorin labeled Fab fragment and biotinylated firefly luciferase
Keywords: پروستات اسید فسفاتاز; Simultaneous bioluminescent assay; Aequorin; Biotinylated firefly luciferase; Tandem bioluminescent immunoassay; Prostate specific antigen; Prostatic acid phosphatase; α-Fetoprotein;
Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells
Keywords: پروستات اسید فسفاتاز; Prostate cancer; Provenge®; Dendritic cell therapy; Prostatic acid phosphatase
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP)
Keywords: پروستات اسید فسفاتاز; Prostatic acid phosphatase; DNA vaccine; Prostate cancer; Rat
New approaches to identification of antigenic candidates for future prostate cancer immunotherapy
Keywords: پروستات اسید فسفاتاز; AMACR; α-methylacyl-CoA racemase; cDNA; complementary deoxyribonucleic acid; CTA; cancer-testis antigen(s); CTL; cytolytic T lymphocyte; ELISPOT; enzyme-linked immunosorbent spot assay; EpCAM; epithelial cell adhesion molecule; HLA; human leukocyte antig
Immunohistochemistry in the diagnosis of minimal prostate cancer
Keywords: پروستات اسید فسفاتاز; Prostate; Carcinoma; 34βE12; p63; AMACR; Prostate-specific antigen; Prostatic acid phosphatase; Histological techniques
GAAAATATGATA-like elements in androgen-associated regulation of the prostatic acid phosphatase gene
Keywords: پروستات اسید فسفاتاز; Prostatic acid phosphatase; Prostate-specific gene regulation; GAAAATATGATA-like elements; Androgen effect; Reporter gene analyses;
Antigen-Presenting Cells 8015 (Provenge®) in Patients with Androgen-Dependent, Biochemically Relapsed Prostate Cancer
Keywords: پروستات اسید فسفاتاز; Dentritic cells; Prostate-specific antigen doubling time; Prostatic acid phosphatase; Radiation therapy;
Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells
Keywords: پروستات اسید فسفاتاز; Vitamin D; Prostate cancer; HER-2; Prostatic acid phosphatase;